Insights

Leadership Expansion Crinetics Pharmaceuticals recently appointed Isabel Kalofonos as Chief Commercial Officer, signaling a strategic focus on expanding its leadership team to drive commercial growth and sales opportunities.

Cutting-Edge Therapies With the launch of CRN09682, a new nonpeptide drug conjugate, Crinetics Pharmaceuticals showcases its commitment to developing innovative therapies that can create avenues for sales in the rare endocrine diseases market.

Financial Strength Having raised $575 million in financing, Crinetics Pharmaceuticals has bolstered its financial position, providing a solid foundation for investment in sales and marketing efforts to capitalize on growth opportunities.

Strategic Partnerships Crinetics Pharmaceuticals collaborating with Cantor Fitzgerald & Co. and Leerink Partners LLC illustrates a proactive approach to forming strategic partnerships that can open up new channels for sales and market expansion.

Market Potential Positioning itself as a potential leader in the endocrinology space, Crinetics Pharmaceuticals is well-poised to leverage market trends and demand for novel therapies, presenting significant sales potential in addressing unmet medical needs.

Crinetics Pharmaceuticals Tech Stack

Crinetics Pharmaceuticals uses 8 technology products and services including Google Font API, PlanSource, Reveal.js, and more. Explore Crinetics Pharmaceuticals's tech stack below.

  • Google Font API
    Font Scripts
  • PlanSource
    Human Resource Management System
  • Reveal.js
    Javascript Frameworks
  • OWL Carousel
    Javascript Libraries
  • YouTube
    Video Players
  • GraphPad Prism
    Visualisation Software
  • Zoom
    Web Conferencing
  • Linkedin
    Widgets

Media & News

Crinetics Pharmaceuticals's Email Address Formats

Crinetics Pharmaceuticals uses at least 1 format(s):
Crinetics Pharmaceuticals Email FormatsExamplePercentage
FLast@crinetics.comJDoe@crinetics.com
93%
Last@crinetics.comDoe@crinetics.com
3%
FirstLast@crinetics.comJohnDoe@crinetics.com
2%
First.Last@crinetics.comJohn.Doe@crinetics.com
2%

Frequently Asked Questions

Where is Crinetics Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Crinetics Pharmaceuticals's main headquarters is located at 6055 Lusk Blvd San Diego, California 92121 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Crinetics Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Crinetics Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Crinetics Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Crinetics Pharmaceuticals is a publicly traded company; the company's stock symbol is CRNX.

What is Crinetics Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Crinetics Pharmaceuticals's official website is crinetics.com and has social profiles on LinkedIn.

How much revenue does Crinetics Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of May 2024, Crinetics Pharmaceuticals's annual revenue reached $75M.

What is Crinetics Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Crinetics Pharmaceuticals's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Crinetics Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of May 2024, Crinetics Pharmaceuticals has approximately 289 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Human Resources Officer: A. C. C.Chief Commercial Officer (cco): J. H.Chief Commercial Officer (cco): I. K.. Explore Crinetics Pharmaceuticals's employee directory with LeadIQ.

What industry does Crinetics Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Crinetics Pharmaceuticals operates in the Biotechnology Research industry.

What technology does Crinetics Pharmaceuticals use?

Minus sign iconPlus sign icon
Crinetics Pharmaceuticals's tech stack includes Google Font APIPlanSourceReveal.jsOWL CarouselYouTubeGraphPad PrismZoomLinkedin.

What is Crinetics Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Crinetics Pharmaceuticals's email format typically follows the pattern of . Find more Crinetics Pharmaceuticals email formats with LeadIQ.

How much funding has Crinetics Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of May 2024, Crinetics Pharmaceuticals has raised $350M in funding. The last funding round occurred on Feb 28, 2024 for $350M.

When was Crinetics Pharmaceuticals founded?

Minus sign iconPlus sign icon
Crinetics Pharmaceuticals was founded in 2008.
Crinetics Pharmaceuticals

Crinetics Pharmaceuticals

Biotechnology ResearchCalifornia, United States201-500 Employees

This place is about more than a pharmaceutical career. It’s about making a real difference in the lives of patients. That’s why we’re here. That’s why you should maybe think about being here, too.

Our mission is to build the leading endocrine company that consistently pioneers new therapeutics to help patients better control their disease and improve their daily lives. Working to accomplish this mission is how we bring our vision to life. For us, that vision is the best possible therapeutics available to all patients with diseases of the endocrine system. We love how that sounds. And we really can’t wait to know how it feels.

Section iconCompany Overview

Headquarters
6055 Lusk Blvd San Diego, California 92121 US
Phone number
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
Stock Symbol
CRNX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
201-500

Section iconFunding & Financials

  • $350M

    Crinetics Pharmaceuticals has raised a total of $350M of funding over 15 rounds. Their latest funding round was raised on Feb 28, 2024 in the amount of $350M.

  • $50M$100M

    Crinetics Pharmaceuticals's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $350M

    Crinetics Pharmaceuticals has raised a total of $350M of funding over 15 rounds. Their latest funding round was raised on Feb 28, 2024 in the amount of $350M.

  • $50M$100M

    Crinetics Pharmaceuticals's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.